| Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC‐MS/MS: application to pharmacokinetics A Rocha, MP Marques, EB Coelho, VL Lanchote Chirality: The Pharmacological, Biological, and Chemical Consequences of …, 2007 | 50 | 2007 |
| Omeprazole preferentially inhibits the metabolism of (+)‐(S)‐citalopram in healthy volunteers A Rocha, EB Coelho, SA Sampaio, VL Lanchote British journal of clinical pharmacology 70 (1), 43-51, 2010 | 43 | 2010 |
| Stereoselective analysis of fluvastatin in human plasma for pharmacokinetic studies VL Lanchote, A Rocha, FUV de Albuquerque, EB Coelho, PS Bonato Journal of Chromatography B: Biomedical Sciences and Applications 765 (1), 81-88, 2001 | 37 | 2001 |
| Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio LF Pippa, ML de Oliveira, A Rocha, JM de Andrade, VL Lanchote Journal of pharmaceutical and biomedical analysis 185, 113231, 2020 | 25 | 2020 |
| Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients ALPC Godoy, A Rocha, C da Silva Souza, VL Lanchote The Journal of Clinical Pharmacology 56 (5), 567-575, 2016 | 24 | 2016 |
| Development and validation of a quantification method for cucurbitacins E and I in rat plasma: Application to population pharmacokinetic studies GML Fiori, S D’Agate, A Rocha, AMS Pereira, O Della Pasqua, NP Lopes Journal of pharmaceutical and biomedical analysis 144, 99-105, 2017 | 18 | 2017 |
| LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses DAC Cusinato, GC de Oliveira Filgueira, A Rocha, MACT Cintra, ... Journal of Pharmaceutical and Biomedical Analysis 164, 430-441, 2019 | 16 | 2019 |
| Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics C de Miranda Silva, A Rocha, E Tozatto, LM da Silva, EA Donadi, ... Journal of Pharmaceutical and Biomedical Analysis 120, 120-126, 2016 | 14 | 2016 |
| Systemic lupus erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of atorvastatin RN Cestari, RDR de Oliveira, FFL de Souza, LF Pippa, GHB Nardotto, ... Clinical and Translational Science 13 (6), 1227-1235, 2020 | 12 | 2020 |
| Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers A Rocha, EB Coelho, SAP Moussa, VL Lanchote European journal of clinical pharmacology 64, 901-906, 2008 | 10 | 2008 |
| Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A E Tozatto, JRL Benzi, A Rocha, EB Coelho, VL Lanchote The Journal of Clinical Pharmacology 61 (3), 319-327, 2021 | 9 | 2021 |
| Therapeutic doses of eltrombopag do not inhibit hepatic BCRP in healthy volunteers: intravenous ceftriaxone as a model DV Neves, CP Vieira, A Rocha, VL Lanchote Journal of Pharmacy & Pharmaceutical Sciences 21, 236-246, 2018 | 9 | 2018 |
| An indirect stereoselective analysis of nebivolol glucuronides in plasma by LC–MS/MS: application to clinical pharmacokinetics CP Vieira, DV Neves, EJ Cesarino, A Rocha, S Poirier, VL Lanchote Journal of Pharmaceutical and Biomedical Analysis 144, 25-30, 2017 | 9 | 2017 |
| No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients GHB Nardotto, VR Bollela, A Rocha, O Della Pasqua, VL Lanchote Clinical and translational science 15 (2), 514-523, 2022 | 8 | 2022 |
| Stereospecific disposition of fluvastatin in streptozotocin-induced diabetic rats A Rocha, EB Coelho, VL Lanchote Canadian journal of physiology and pharmacology 80 (11), 1071-1075, 2002 | 8 | 2002 |
| Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients … ML de Oliveira, A Rocha, GHB Nardotto, LF Pippa, BP Simoes, ... Journal of Pharmaceutical and Biomedical Analysis 191, 113576, 2020 | 7 | 2020 |
| Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation … JR de Lima Benzi, A Rocha, JC Colombari, AMG Pego, ... Journal of Pharmaceutical and Biomedical Analysis 235, 115635, 2023 | 5 | 2023 |
| P‐glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV FL Moreira, PPS Melli, MP Marques, A Rocha, GHB Nardotto, G Duarte, ... The Journal of Clinical Pharmacology 63 (2), 219-227, 2023 | 5 | 2023 |
| Clinical treatment for hepatitis C reverses CYP2C19 inhibition LF Pippa, CP Vieira, JA Caris, A Rocha, CP Garcia, REF Rezende, ... British Journal of Clinical Pharmacology 87 (10), 4013-4019, 2021 | 5 | 2021 |
| Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical … RN Cestari, A Rocha, MP Marques, RDR de Oliveira, VL Lanchote Journal of Chromatography B 1126, 121766, 2019 | 5 | 2019 |
